sanfetrinem

An orally available tricyclic beta-lactam (trinem) antibiotic, with broad-spectrum activity against gram-positive and gram-negative bacteria… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1996-2017
024619962017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
It has been previously demonstrated that some antimicrobial agents enhance activities of human polymorphonuclear neutrophils… (More)
Is this relevant?
1999
1999
The antimicrobial activities of trovafloxacin, moxifloxacin, sanfetrinem, quinupristin-dalfopristin, and 14 other antimicrobial… (More)
Is this relevant?
1998
1998
Sanfetrinem is a trinem beta-lactam which can be administered orally as a hexatil ester. We examined whether its beta-lactamase… (More)
Is this relevant?
1998
1998
The in vivo antibacterial activities of a new oral trinem, sanfetrinem cilexetil (a prodrug of sanfetrinem), were evaluated in… (More)
Is this relevant?
1998
1998
The entry of antibiotics into phagocytes is necessary for activity against intracellular pathogens. The ability of sanfetrinem… (More)
  • table 1
  • table 2
  • table 4
  • table 3
  • table 5
Is this relevant?
1997
1997
Agar dilution MIC methodology was used to test the activities of GV 118819X (sanfetrinem), ampicillin, amoxicillin, amoxicillin… (More)
Is this relevant?
1997
1997
The postantibiotic effect (PAE) and postantibiotic sub-MIC effect (PAE-SME) of sanfetrinem were compared to those of penicillin G… (More)
Is this relevant?
1997
1997
1. The absorption, distribution, metabolism and excretion of sanfetrinem have been investigated in the rat and dog after… (More)
Is this relevant?
1997
1997
The trinem sanfetrinem (GV 104326) was administered as the oral hexetil prodrug GV 118819X in two dose levels to six healthy… (More)
Is this relevant?
1996
1996
The in vitro activity of the trinem sanfetrinem (formerly GV104326) (GV) was compared with that of vancomycin, ampicillin, and/or… (More)
Is this relevant?